6505--Abiraterone Acetate Tablets
ID: 36E79724R0023Type: Presolicitation
Overview

Buyer

VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OFNAC PHARMACEUTICALS (36E797)HINES, IL, 60141, USA

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

DRUGS AND BIOLOGICALS (6505)

Original Source

https://sam.gov/opp/0822fc14cd314401bcf735732d6edae0/view
Timeline
    Description

    The Department of Veterans Affairs (VA) intends to issue a Request for Proposal (RFP) for the procurement of Abiraterone Acetate Tablets, identified by solicitation number 36E79724R0023. This procurement aims to secure a reliable supply of these pharmaceutical products for the VA, Department of Defense (DoD), Bureau of Prisons (BOP), Indian Health Service (IHS), and other federal healthcare entities, emphasizing the need for uninterrupted supply and compliance with specific labeling and packaging requirements. The estimated annual requirements include 71,997 bottles of 120-count 250mg tablets and 1,102 bottles of 60-count 500mg tablets, with the RFP scheduled for electronic release on approximately September 18, 2024, and a closing date of October 2, 2024. Interested vendors can direct inquiries to Contract Specialist Richard Mahario at Richard.Mahario@va.gov or by phone at 708-786-5247, and must regularly check SAM.gov for updates as no paper copies of the solicitation will be provided.

    Point(s) of Contact
    Richard MaharioContract Specialist
    (708) 786-5247
    Richard.Mahario@va.gov
    Files
    Title
    Posted
    36E79724R0023_1.docx
    The Department of Veterans Affairs (VA) intends to issue a Request for Proposal (RFP) for the procurement of Abiraterone Acetate Tablets, identified by solicitation number 36E79724R0023. This procurement aims to secure a reliable supply for the VA, Department of Defense (DoD), Bureau of Prisons (BOP), Indian Health Service (IHS), and other federal healthcare entities. The contract will span one year, with four possible one-year extensions, emphasizing uninterrupted supply and specific labeling requirements for each offeror. Interested vendors must identify unique National Drug Codes (NDC) and ensure compliance with packaging specifications, including dimensions and safety caps. The estimated annual needs include 71,997 bottles of 120-count 250mg tablets and 1,102 bottles of 60-count 500mg tablets. The RFP will be electronically released on approximately September 18, 2024, with a closing date of October 2, 2024. Offerors must check SAM.gov for updates, as no paper copies of the solicitation will be provided. For inquiries, potential bidders can contact Contract Specialist Richard Mahario via email or phone. This procurement reflects the VA's commitment to meeting the pharmaceutical needs of veterans and other designated agencies.
    Lifecycle
    Title
    Type
    6505--Abiraterone Acetate Tablets
    Currently viewing
    Presolicitation
    Similar Opportunities
    6505--Norethindrone 5mg Tablet (VA-25-00005551)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is issuing a presolicitation notice for Request for Proposal (RFP) 36E79724R0027, aimed at procuring Norethindrone Acetate Tablets (5mg) for various federal entities, including the Department of Defense (DoD), Bureau of Prisons (BOP), Indian Health Service (IHS), and State Veterans Homes (SVH). The successful offeror will be required to provide an uninterrupted supply of the tablets, with a contract period of one year and four optional renewal years, and must adhere to specific labeling and packaging standards, including a unique NDC number and safety-cap design. This procurement is critical for ensuring the availability of essential medication for veterans and other federal health care facilities, with an estimated annual requirement of 13,202 bottles, each containing 50 tablets. Interested parties should submit their proposals by November 1, 2023, following the electronic release of the solicitation on or about October 18, 2023, and can direct inquiries to Contract Specialist Adrienne Albachiara at adrienne.albachiara@va.gov.
    6505--Levothyroxine Tablets (VA-24-00084562)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) intends to solicit proposals for the procurement of Levothyroxine Sodium Tablets under Request for Proposal (RFP) 36E79724R0020. This procurement aims to secure an uninterrupted supply of these essential medications for various VA facilities, including Consolidated Mail Order Pharmacies, State Veterans Homes, the Indian Health Service, and the Federal Health Care Center. The contract will span one year, with the possibility of four additional pre-priced option periods, reflecting the VA's commitment to meeting the pharmaceutical needs of veterans. Interested suppliers must submit their proposals by September 30, 2024, and can direct inquiries to Contract Specialist Youlanda Duggar at Youlanda.duggar@va.gov or by phone at 708-786-4943.
    Rabeprazole Sodium Delayed Release Tablets
    Active
    Dept Of Defense
    Presolicitation DEPT OF DEFENSE is planning to issue a national requirements contract for Rabeprazole Sodium Delayed Release Tablets. The tablets will be used for medical purposes and will be available in 30, 90, and 500 count bottles. The contract will be a firm-fixed price, requirements type contract with a one year base and four one year options. The contract aims to establish a national supply source to provide the tablets for purchase by Department of Defense, Department of Veterans Affairs, Indian Health Service, and Bureau of Prisons customers. Interested parties should contact Phyllis Daraio for more information. The projected solicitation date is February 2020.
    6505--Zolmitriptan Tablets (VA-25-00006129)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is soliciting bids for the procurement of Zolmitriptan tablets, as outlined in solicitation number VA-25-00006129. This contract aims to establish a reliable source of pharmaceutical supplies for federal healthcare programs, emphasizing compliance with the Drug Supply Chain Security Act (DSCSA) and good manufacturing practices as mandated by the FDA. The selected contractor will be responsible for providing competitive pricing for both the base year and four option years, ensuring that all products meet safety and regulatory standards. Interested parties should contact Contract Specialist Kenneth Lay at Kenneth.Lay@va.gov for further details and to discuss submission requirements.
    762-24-3-040-2385 -Tucson CMOP ACAMPROSATE -(VA-24-00083915)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking offers for the procurement of Acamprosate 333mg EC tablets under solicitation number 36C77024Q0392, aimed at fulfilling its pharmaceutical needs. Vendors are required to submit a comprehensive proposal that includes pricing schedules, valid state licenses, and compliance certifications, with a focus on maintaining high standards for drug quality and adherence to regulatory requirements. This procurement is crucial for ensuring the availability of essential medications for veterans, reflecting the government's commitment to supporting small businesses through a total small business set-aside. Interested vendors must submit their bids by September 17, 2024, at 4:00 PM CST, and can contact Sarah Fry at sarah.fry2@va.gov or 913-758-9935 for further information.
    6505--Prasugrel HCL 5mg and 10mg 30 Count Bottles
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is soliciting proposals for the procurement of Prasugrel Hydrochloride (HCL) tablets in 5mg and 10mg 30 count bottles. The procurement aims to establish a reliable supply chain for these pharmaceutical products, which are critical for the healthcare of veterans and related agencies, ensuring compliance with federal regulations and the Drug Supply Chain Security Act (DSCSA). Offerors must provide pricing for a base year and four optional one-year periods, demonstrate manufacturing and distribution capabilities, and adhere to stringent reporting and safety standards. Interested contractors should contact Contract Specialist Matthew S. Poulin at Matthew.Poulin@va.gov for further details regarding the solicitation process.
    6505--Bupropion Tablets
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is soliciting proposals for the procurement of Bupropion Hydrochloride tablets, aimed at supporting veterans and related entities through its Pharmaceutical Prime Vendor Programs. Offerors are required to submit pricing that includes a 0.5% Cost Recovery Fee and provide unique National Drug Code (NDC) numbers for their products, while ensuring compliance with the Drug Supply Chain Security Act (DSCSA) and FDA regulations. This procurement is crucial for maintaining a reliable pharmaceutical supply for VA healthcare facilities, with an emphasis on participation from small and disadvantaged businesses. Interested parties can reach out to Contract Specialist Andrew J. Cazares at Andrew.Cazares@va.gov for further details.
    Telmisartan Tablets
    Active
    Dept Of Defense
    Presolicitation DEPT OF DEFENSE is planning to issue a national requirements contract for Telmisartan Tablets. Telmisartan Tablets are pharmaceutical preparations used to treat high blood pressure and reduce the risk of heart attack, stroke, and kidney problems in certain patients. The tablets will be available in 20MG, 40MG, and 80MG strengths, packaged in 30 count bottles. This will be an unrestricted and fully competitive acquisition. The contract will be a firm-fixed price, requirements type contract with a one-year base and four one-year options. The contract aims to establish a national supply source to provide Telmisartan Tablets to Department of Defense, Bureau of Prisons, Indian Health Service, and Department of Veterans Affairs customers through the DLA and VA prime vendor programs. Interested parties can contact Courtney Hunter-Stangler at (215) 737-6845 or Courtney.Hunter-Stangler@dla.mil for any questions/comments. The solicitation is projected to be issued in August of 2024.
    Rizatriptan Benzoate
    Active
    Dept Of Defense
    Presolicitation DEPT OF DEFENSE is planning to issue a national requirements contract for Rizatriptan Benzoate tablets. The contract will establish a national supply source to provide the items listed in the schedule for purchase by Department of Defense, Department of Veterans Affairs, Indian Health Service, and Bureau of Prisons customers. The contract will be a firm-fixed price, requirements type contract with a one year base and four one year options. The solicitation will be posted on the DLA Bid Board System and SAM.gov. Interested parties should contact Keith Ryales for any questions/comments. The projected solicitation date is June 2022.
    Valsartan
    Active
    Dept Of Defense
    Presolicitation DEPT OF DEFENSE is planning to issue a national requirements contract for Valsartan, a drug used for treating high blood pressure and heart failure. The contract will include Valsartan tablets in various strengths and quantities. It will be a firm-fixed price, requirements type contract with a one year base and four one year options. The contract aims to establish a national supply source for Department of Defense, Department of Veterans Affairs, Indian Health Service, and Bureau of Prisons customers. Interested parties can contact Catherine Gilbert for more information. The solicitation is projected to be issued in December 2019.